Diffuse Large B Cell Lymphoma (DLBCL) Patient Survey
If you have or had Diffuse Large B Cell Lymphoma (DLBCL), you can help by completing our survey. Lymphoma Canada is preparing a submission for the pan-Canadian Oncology Drug Review (pCODR). The survey provides us with the patient input required for the submission. pCODR uses this information to help them make recommendations to Canadian public drug plans regarding funding for new cancer drugs. The funding request under review is: CAR-T cell therapy for relapsed Diffuse Large B Cell Lymphoma (DLBCL) You do not need to live in Canada to complete this survey. BY COMPLETING THIS SURVEY, YOU ARE PART OF THE PROCESS THAT MAY HELP PATIENTS GAIN ACCESS TO THIS TREATMENT IN CANADA. The survey will be open until midnight Pacific Time on Thursday, May 31, and should only take 10 minutes of your time. Please share and help us spread the word. Thank you for your support.
Share Your Experience: Take our Canadian Liver Cancer Patient & Caregiver Survey
Are you a patient, caregiver, or family member/friend affected by liver cancer & living in Canada? Please take a moment to complete our Canadian liver cancer patient & caregiver survey. The purpose of this short survey is to help the Canadian Cancer Survivor Network (CCSN) better understand the issues that patients and non-patients face with primary liver cancer diagnosis and treatment. By participating in this survey, you will be helping CCSN to shape messages for its upcoming advocacy efforts aimed at improving the lives of liver cancer patients, with the goal of furthering treatments and removing stigma. Liver cancer is stigmatized, and Canada is huge. It can be difficult to reach the patients who need our help the most, and our goal is to get this message to as many people as we can. You too can help increase liver cancer advocacy in Canada by sharing this survey with those you know. Thank you!
Cancer Survivors Invited for Survivors’ Lap at Relay for Life Ottawa
Relay For Life Ottawa is an inspirational, non-competitive, 12-hour overnight fundraising event that brings our community together to celebrate life and fight cancer. Relay’s festival-like atmosphere can be enjoyed regardless of age or fitness level.
Join us on Friday night, June 15th at 7pm when teams complete laps, participate in fun activities, refuel with delicious food and remember and honour those who are currently facing cancer and those we have lost. This year we will have one large Relay for Life Ottawa event that will be held at Charmaine Hooper Fields, 39 Colonnade Road.
We welcome survivors to participate in the opening ceremony and survivors’ lap, which kicks off the evening. This is a time for you to connect with others, share your passion for making a difference, celebrate our accomplishments and help to change the impact cancer has on our community. Join us for an amazing night. No one should face cancer alone. Be with us as we support those on the journey. Be with us as we fight back.
Share Your Thoughts: Help KCA Uncover Unmet Needs In Kidney Cancer/RCC
The Kidney Cancer Association (KCA) would like to learn more about your experience after undergoing surgery for kidney cancer/renal cell carcinoma (RCC) in order to uncover unmet needs in education, resources and treatment.
In an effort to better assess the current knowledge level surrounding what adjuvant therapy is and how it could play a role for RCC patients who are at high risk of recurrence, we have partnered with CancerCare, Pfizer, Inc. and Kelton, a leading international research firm, to conduct this survey among people who were diagnosed with kidney cancer/RCC and had recent surgery to treat their cancer within the past 6 months to 2 years. The survey takes about 10 to 12 minutes to complete. To access the survey please click on the following link or type the URL in the address bar of your web browser and press “enter:” http://v2.decipherinc.com/survey/selfserve/bb6/180200
If you have any questions, concerns, or problems with the survey, please click here.
KCA, Pfizer, Inc. and Kelton greatly appreciate your help and opinions as your insight will guide the development of educational tools and resources for the RCC community. We value your privacy and pledge never to share your information.
Thank you in advance for your time and participation.
Building A Voice for Primary Liver Cancer Patients & Caregivers in Canada
Has liver cancer affected you or someone you know? The Canadian Cancer Survivor Network is looking for patients, caregivers, families, clinicians and others affected by hepatocellular carcinoma (HCC), the most common form of primary liver cancer. We are building new website content and an awareness campaign surrounding primary liver cancer, and would like to invite you to join our HCC Advisory Council. This is a fantastic opportunity to make a difference for you and other individuals in Canada affected by liver cancer. To get involved, please contact us!
ON & QC Volunteers Needed for Study on Self-Care After Cancer
A McGill University-Princess Margaret Cancer Centre research team is offering free self-care tools (relaxation/mindfulness CDs/MP3s & cognitive behavioral therapy skills-enhancing workbooks) as well as telephone coaching to eligible persons aged 18 and over in a study funded by the Canadian Cancer Society.
Sleep Well Study with The Ottawa Hospital
A study on the effectiveness of an online treatment for insomnia. The Ottawa Hospital is looking for participants with insomnia who have completed cancer treatments.
The MATCH Study: Now Recruiting!
A ground-breaking new study measuring the effects of Mindfulness Meditation and Tai Chi/Qigong on quality of life for cancer survivors.
PROSTAID Calgary’s 2018 Symposium
Cancer is one of the world’s most pressing health care challenges. PROSTAID Calgary’s Cancer Advocacy Symposium will create an interactive and collaborative forum between Alberta politicians and policymakers, and Alberta’s cancer community. This call for volunteers is an opportunity to come together in a collaborative setting to discuss the most pressing issues facing Alberta’s healthcare system.